Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 10Urinary Bladder Neoplasms 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Recurrence 1Non-Muscle Invasive Bladder Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Leiomyosarcoma 1Esophageal Neoplasms 1Disease Progression 1Breast Diseases 1Amenorrhea 1

Interventions

Cyclophosphamide 17fludarabine phosphate 12Rituximab 12Peripheral Blood Stem Cell Transplantation 12Filgrastim 11Cyclosporine 11Whole-Body Irradiation 8Mycophenolic Acid 8Radiotherapy 7Busulfan 7Antilymphocyte Serum 7Vincristine 6Prednisone 6Melphalan 6Etoposide 6Methotrexate 5Psychiatric Rehabilitation 4Methylprednisolone 4Cord Blood Stem Cell Transplantation 4Therapeutics 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Doxorubicin 3Cytarabine 3Carmustine 3Aprepitant 3Analgesia 3plerixafor 2Vindesine 2Tacrolimus 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Large B-Cell, Diffuse × Epirubicin × Clear all
NCT03022123 2017-01-16

The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma

Hebei Medical University Fourth Hospital

Phase NA Unknown
270 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡